Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The γ-globin gene promoter is a regulatory DNA sequence upstream of the human γ-globin genes (HBG1 and HBG2). It controls the transcriptional activity of these genes, which are primarily expressed during fetal development and silenced after birth. Regulation of this promoter is central to developmental hemoglobin switching and a therapeutic target for hemoglobinopathies.
Modulation of γ-globin gene expression through transcription factor binding and epigenetic modifications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on γ-globin Gene Promoter (γ-globin promoter).